AW
IRWD icon

Avion Wealth’s Ironwood Pharmaceuticals IRWD Stock Holding History

Avion Wealth’s Portfolio IRWD Stock Details IRWD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2K Buy
516
+108
+26% +$416 ﹤0.01% 1072
2026
Q1 		$1K Hold
408
– – ﹤0.01% 1062
2025
Q4 		$1K Hold
408
– – ﹤0.01% 1056
2025
Q3 		$0 Buy
+408
New +$422 ﹤0.01% 1378
2023
Q3 		– Sell
-94
Closed – – 1004
2023
Q2 		$0 Buy
+94
New +$1.01K ﹤0.01% 885

Other funds holding IRWD

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
AC
Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return
SCM
Sarissa Capital Management Greenwich, Connecticut $178M AUM 118.43% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Avion Wealth's IRWD Position: Q2 2026 in Review

Avion Wealth increased its Ironwood Pharmaceuticals (IRWD) stake by 26% in Q2 2026, buying an estimated $416 and bringing the position to 516 shares worth $2K. The position accounts for ﹤0.01% of the portfolio, ranked #1072.

Avion Wealth first reported a position in IRWD in Q2 2023 and has held it in 5 quarters since. 212 funds tracked by Wall St. Rank hold IRWD as of Q2 2026.

  • Avion Wealth held 516 shares of Ironwood Pharmaceuticals worth $2K as of Q2 2026.
  • Avion Wealth bought 108 Ironwood Pharmaceuticals shares in Q2 2026, an estimated $416.
  • Ironwood Pharmaceuticals made up ﹤0.01% of Avion Wealth's portfolio in Q2 2026, its #1072 holding.
  • Avion Wealth first reported a position in Ironwood Pharmaceuticals in Q2 2023 and has held it in 5 quarters since.
  • 212 funds tracked by Wall St. Rank held Ironwood Pharmaceuticals as of Q2 2026.

Based on Avion Wealth's 13F filing for Q2 2026, filed 31 Jul 2026.